Apyx Medical Management
Management criteria checks 2/4
Apyx Medical's CEO is Charlie Goodwin, appointed in Dec 2017, has a tenure of 6.92 years. total yearly compensation is $1.26M, comprised of 38.2% salary and 61.8% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth $126.00K. The average tenure of the management team and the board of directors is 0.9 years and 5.3 years respectively.
Key information
Charlie Goodwin
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 38.2% |
| CEO tenure | 6.9yrs |
| CEO ownership | 0.2% |
| Management average tenure | less than a year |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?
Sep 14
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 07We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed
Aug 01Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?
Jun 19Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Apr 18Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Mar 26Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)
Feb 16Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically
Mar 21Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Aug 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$1m | US$483k | -US$19m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$21m |
| Dec 31 2022 | US$2m | US$483k | -US$23m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$2m | US$450k | -US$15m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$2m | US$450k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$16m |
| Jun 30 2020 | n/a | n/a | -US$16m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$2m | US$450k | -US$20m |
| Sep 30 2019 | n/a | n/a | -US$18m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$1m | US$400k | -US$11m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$12m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$2m | US$15k | -US$14m |
Compensation vs Market: Charlie's total compensation ($USD1.26M) is above average for companies of similar size in the US market ($USD653.78K).
Compensation vs Earnings: Charlie's compensation has been consistent with company performance over the past year.
CEO
Charlie Goodwin (58 yo)
6.9yrs
Tenure
US$1,261,470
Compensation
Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.9yrs | US$1.26m | 0.24% $ 126.0k | |
| CFO, Treasurer & Secretary | less than a year | US$445.95k | 0.021% $ 11.0k | |
| Senior Vice President | 12.8yrs | US$538.31k | 1.21% $ 639.1k | |
| Executive Chairman | less than a year | no data | 4.64% $ 2.4m | |
| Chief Operating Officer | no data | no data | no data |
0.9yrs
Average Tenure
55yo
Average Age
Experienced Management: APYX's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.9yrs | US$1.26m | 0.24% $ 126.0k | |
| Executive Chairman | less than a year | no data | 4.64% $ 2.4m | |
| Lead Independent Director | 13.7yrs | US$162.56k | 0.11% $ 60.1k | |
| Member of Medical Advisory Board | 5.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | US$9.30k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 5.3yrs | US$116.56k | 0% $ 0 | |
| Member of Medical Advisory Board | 7.8yrs | no data | no data | |
| Member of Medical Advisory Board | 6.5yrs | no data | no data | |
| Member of Medical Advisory Board | 5.3yrs | no data | no data | |
| Member of Medical Advisory Board | 5.3yrs | no data | no data | |
| Member of Medical Advisory Board | 5.3yrs | no data | no data |
5.3yrs
Average Tenure
69yo
Average Age
Experienced Board: APYX's board of directors are considered experienced (5.3 years average tenure).